Nuclear Medicine in Belgium

14 – 15 Oct 2026 | Suarlée, Belgium

HomeAgendaParticipantsMarketplace

14 October 2026 - 15 October 2026

5020 Suarlée, Belgium

Business Village Ecolys , av. d’Ecolys, 2

Nuclear Medicine in Belgium

Registration ended on 9 Oct 2026

What's in it?

15

Sessions

33

Speakers

9

Participating countries

Why attend this international event? 

Belgium stands out as one of the most advanced and integrated hubs for nuclear medicine in Europe, boasting a comprehensive value chain that spans from research and development to patient delivery.

Participating in Nuclear Medicine in Belgium provides a rare opportunity to strategically engage with key stakeholders and foster high-value international collaborations.

Scheduled strategically just before the European Association of Nuclear Medicine (EANM) Global Annual Congress, this initiative promises an exceptional immersive experience featuring:

A Two-Day Immersive Program: Engage in a dynamic agenda that combines insightful industrial site visits with strategic discussions.

Direct Access to Senior Decision-Makers: Network with influential leaders across the entire nuclear medicine value chain.

Expert Insights: Benefit from keynote testimonials and presentations by Key Opinion Leaders (KOLs) on the latest industry trends and advancements.

Targeted B2B Meetings: Participate in exclusive networking opportunities designed to facilitate valuable connections and collaborations.

Join us to unlock the full potential of nuclear medicine in Belgium and elevate your international partnerships!

 DAY 1 - October 14

A rare opportunity to access critical infrastructure shaping the future of advanced radiopharmaceuticals:

Full Life Technologies Europe (Gembloux) 

 A brand-new state-of-the-art facility dedicated to the production and processing of actinium-225 — a cornerstone for the next generation of targeted alpha therapies.

TELIX Manufacturing Solutions (Seneffe),
in partnerships with Trasis & Elysia-Raytest

A global radiopharmaceutical company focused on  precision oncology. It's Seneffe site serves as a major european production and Innovation hub.

IRE, Institute for Radioalements (Fleurus), in partnership with IBA 

A global leader in medical isotope production. A unique opportunity to discover their newly acquired IBA cyclotron strengthening Germanium-68 production, along with their new CDMO capabilities.

DAY 2 - October 15

High-Level Seminar & Strategic Discussions

Access one of the world’s most integrated nuclear medicine ecosystems in a single day — and identify concrete entry points for collaboration.

This high-level seminar brings together industry leaders, clinicians, researchers, regulators, clusters, and public authorities to discuss the latest trends and strategic developments in the field of nuclear medicine.

Strategic focus areas:

Innovation & Scale-Up – Through business case presentations and roundtables with C-level leaders, participants will explore how innovations move from R&D to clinical translation and industrial deployment in nuclear medicine.

Talent & Awareness– Experts will discuss practical strategies to close the talent gap and strengthen the global visibility and attractiveness of the nuclear medicine field.


Regulation & Market Access 
– Industry leaders and regulators will exchange perspectives to streamline regulatory pathways and accelerate international market access for innovative solutions.


Ecosystem Power 
– Discover how coordinated clusters and partnerships will transform regional excellence into European leadership with global impact.

Gold Sponsors

Silver sponsors

With the support of

Moderation Track Sponsor

Knowledge partners

Supporting partner clusters

It's time to